F8 gene dosage defects in atypical patients with severe haemophilia A


Por: Vencesla, A, Baena, M, Garrido, RP, Nunez, R, Velasco, F, Rosell, J, Villar, A, Jimenez-Yuste, V, Baiget, M, Tizzano, EF

Publicada: 1 sep 2012
Resumen:
. We performed molecular analysis of the factor 8 gene (F8) in 272 unrelated Spanish patients with haemophilia A (HA) and detected a mutation by routine analysis in 267 of them (98.1%). No mutation was detected in the remaining five patients despite clinical and laboratory confirmation of HA. The aim is to describe the molecular alterations in F8 discovered by gene dosage methodologies in three of these patients. For methodology, F8 sequencing, intragenic marker analysis, multiplex ligation-dependent probe amplification and quantitative real time-PCR were followed. One patient had Klinefelter syndrome (47,XXY) and a large deletion spanning exons 112 masked by the other F8 allele; the second patient showed a large duplication spanning exons 210 and the third patient revealed a non-contiguous double duplication of exons 14 and 2325. The remaining two patients had mild HA and dosage results were normal. The application of gene dosage methods is useful to define haemophilic patients in whom mutations are not detected using other routine methods. Nevertheless, in a small percentage of patients (<1%), no molecular pathology can be identified after testing several genetic methodologies.

Filiaciones:
Vencesla, A:
 Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08025, Spain

 CIBERER U705, Barcelona 08025, Spain

Baena, M:
 Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08025, Spain

 CIBERER U705, Barcelona 08025, Spain

Garrido, RP:
 Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08025, Spain

 CIBERER U705, Barcelona 08025, Spain

 Hosp Virgen del Rocio, Unidad Hemofilia, Seville, Spain

Nunez, R:
 Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08025, Spain

 CIBERER U705, Barcelona 08025, Spain

 Hosp Virgen del Rocio, Unidad Hemofilia, Seville, Spain

Velasco, F:
 Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08025, Spain

 CIBERER U705, Barcelona 08025, Spain

 Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain

Rosell, J:
 Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08025, Spain

 CIBERER U705, Barcelona 08025, Spain

 Hosp Son Espases, Serv Genet, Palma De Mallorca, Spain

Villar, A:
 Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08025, Spain

 CIBERER U705, Barcelona 08025, Spain

 Hosp La Paz, Unidad Hemofilia, Madrid, Spain

Jimenez-Yuste, V:
 Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08025, Spain

 CIBERER U705, Barcelona 08025, Spain

 Hosp La Paz, Unidad Hemofilia, Madrid, Spain

Baiget, M:
 Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08025, Spain

 CIBERER U705, Barcelona 08025, Spain

Tizzano, EF:
 Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08025, Spain

 CIBERER U705, Barcelona 08025, Spain
ISSN: 13518216





HAEMOPHILIA
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: 18 Número: 5
Páginas: 708-713
WOS Id: 000307900700027
ID de PubMed: 22621702

MÉTRICAS